Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex(®)) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion

Macular edema is a common cause of visual loss in patients with retinal vein occlusions. Ozurdex(®), a dexamethasone intravitreal implant, has been shown in randomized controlled trials to reduce macular edema and improve visual acuity in patients with either branch retinal vein occlusions or centra...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Annie, Leung, Loh-Shan, Blumenkranz, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151568/
https://www.ncbi.nlm.nih.gov/pubmed/21845032
http://dx.doi.org/10.2147/OPTH.S13775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151568/
https://www.ncbi.nlm.nih.gov/pubmed/21845032
http://dx.doi.org/10.2147/OPTH.S13775

Ejemplares similares